期刊文献+

体检人群代谢因素与前列腺增生的相关性分析:肥胖是其独立危险因素 被引量:4

Association of benign prostatic hyperplasia with metabolic factors in routine examination population-obesity is an independent risk factor
下载PDF
导出
摘要 目的试探寻代谢因素与前列腺增生发生的相关性。方法收集2011年1月1日~2011年7月31日于福建省立医院常规体检男性资料。检测项目包括:身高与体重以计算BMI;采血检验:血糖、甘油三脂、胆固醇、低密度脂蛋白、高密度脂蛋白、前列腺特异性抗原(PSA);B超:测量前列腺体积。结果入选患者1 861例,前列腺体积正常与增大组间各均值比较显示年龄(47 vs.69,P=0.002)、BMI(22.1 vs.27.5,P=0.001)、PSA(0.72 vs.1.58,P=0.034)水平存在显著统计学差异。校正年龄影响,相关性单因素分析:PSA升高、超重、肥胖是前列腺体积增大的危险因素(OR值分别为5.507、P=0.028,1.565、P=0.036,2.112,P=0.003);多因素分析:肥胖是前列腺体积增大的独立危险因素,肥胖者发生前列腺增大的风险是体重正常者的2.396倍,P=0.001。而PSA升高(OR3.349,P=0.116)与体重超重(OR1.210,P=0.071)的作用被削减,为无统计学差异,并非影响前列腺体积增大的独立危险因素。结论肥胖(BMI≥28kg/m2)是前列腺增大的独立危险因素。锻炼、控制体重可以降低前列腺增生发生的风险;并可作为前列腺增生患者生活方式干预的重要措施。 Objective To determine whether the metabolic factors are associated with prostate volume. Methods A total of 1 861 men were enrolled in the study who received health examinations at the healthcare center of Fujian Provincial Hospital between 2011.1.1--2011.7.31. Their anthropometrical factors were measured and serum fasting blood glucose, triglyceride, cholesterol, high-density lipoprotein, 10w-density lipoprotein, and prostate-specific antigen levels were analyzed. Prostate volume was measured by ultrasongraphy. Results The mean prostate volume was 26.4 mL, and the mean body mass index (BMI) was 25.4 kg/m2. By age-adjusted single logistic regression, PSA〉4 ng/mL, overweight and obesity were associated with increased risk of developing prostatic hyperplasia (OR 5. 507, P=0. 028; 1. 565, P=0. 036; 2. 112, P=0. 003; respectively). Both PSA and overweight became non-significant ( OR 3. 349, P = 0.116 ; 1.210, P = 0. 071 ; respectively), but only obesity (BMI 〉; 28 kg/m2) was still validated by multiple logistic regression (OR 2. 396, P=0. 001). Conclusions BMI ≥28 kg/m2 is an independent risk factor of developing prostatic hyperplasia. It supports the development of novel prevention and treatment strategies of BPH by weight control.
出处 《现代泌尿外科杂志》 CAS 2013年第3期254-257,共4页 Journal of Modern Urology
关键词 前列腺增生 代谢 BMI 肥胖 前列腺特异性抗原 prostatic hyperplasia metabolic BMI obesity prostate-specific antigen
  • 相关文献

参考文献22

  • 1吴阶平.泌尿外科 [M].济南:山东科学技术出版社,2004:1143-1155.
  • 2PARSONS JK,CARTER HB,PARTIN AW,et al.Metabolic factors associated with benign prostatic hyperplasia [J].J Clin Endocrinol Metab,2006,91 (7):2562.
  • 3JOSEPH MA,WEI JT,HARLOW SD,et al.Relationship of serum sexsteroid hormones and prostate volume in African American men [J].Prostate,2002,53(4):322-329.
  • 4LEE S,MIN HG,CHOI SH,et al.Central obesity as a risk factor for prostatic hyperplasia [J].Obesity,2006,14(1):172-179.
  • 5SARMA AV,JAFFE CA,SCHOTTENFELD D,et al.Insulinlike growth factor1,insulinlike growth factor binding protein3,and body mass index:clinical correlates of prostate volume among Black men [J].Urology,2002,59(3):362-367.
  • 6FREEDLAND SJ,PLATZ EA,PRESTI JC,et al.Obesity,serum prostate specific antigen and prostate size:implications for prostate cancer detection [J].J Urol,2006,175(2):500-504.
  • 7GIOVANNUCCI E,RIMM EB,CHUTE CG,et al.Obesity and benign prostatic hyperplasia [J].Am J Epidemiol,1994,140(11):989-1002.
  • 8DAHLE SE,ANAND P,GAO YT,et al.Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia [J].J Urol,2002,168(2):599-604.
  • 9FIRAS A,BRIGANTI A,SUARDI N,et al.Metabolic syndrome and benign prostatic hyperplasia:evidence of a potential relationship,hypothesized etiology,and prevention [J].Korean J Urol,2011,52(8):507-516..
  • 10ZUCCHETTO A,TAVANI A,DAL ML,et al.History of weight and obesity through life and risk of benign prostatic hyperplasia [J].Int J Obes,2005,29(7):798-803.

二级参考文献10

  • 1李培军,张祥华,郭利君,那彦群.高血压对良性前列腺增生细胞增殖与凋亡的影响[J].中华男科学杂志,2005,11(2):94-97. 被引量:31
  • 2Kasturi S, Russell S, Mcvary KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep, 2006,7: 288-292.
  • 3Dahle SE, Chokkalingam AP, Gao YT, et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol, 2002, 168.. 599-604.
  • 4Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol, 2001; 39: 151-158.
  • 5Ozden C, Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol, 2007, 51:199 206.
  • 6Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective. Science, 1998, 279:563 566.
  • 7Lee S, Min HG, Choi SH, el al. Central obesity as a risk factor for prostatic hyperplasia. Obesity, 200G, 14: 172-179.
  • 8Nandeesha H, Koner BC, Dorairajan LN, el al. Hyperinsulinemia and dyslipidemia in non diabetic benign prostatic hyperplasia. Clinica 2006, 370:89 93.
  • 9沈芳,屈晓冰.良性前列腺增生与代谢综合征关系的研究进展[J].中华老年医学杂志,2010,29(4):343-346. 被引量:16
  • 10刘颖,屈晓冰,董莉妮,沈芳.老年人良性前列腺增生症与胰岛素抵抗[J].中华老年医学杂志,2010,29(11):896-898. 被引量:12

共引文献7

同被引文献29

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部